If Mitt Romney wins the presidential election tomorrow, one of the first things he has vowed to do upon taking office is to strike down President Obama's legacy: the Patient Protection and Affordable Care Act. In this video, health care analyst Brenton Flynn outlines what that would mean for the health care sector and how it could benefit the medical device companies that are currently scrambling, as new taxes under Obama's plan potentially loom on the horizon. Conversely, Flynn takes a look at health care facilities and how they stand to benefit from a Romney loss.
This election has the potential to either boost or hamstring MAKO Surgical, and with the recent market sell-off of the company's shares, many are wondering whether the potential growth prospects robotic surgery make this stock a buy or one to stay away from. To answer this question, Fool.com analyst and MAKO expert David Meier has authored a premium research report covering all of the must-know details on the company, including key areas to watch and risks looming in the future. As an added bonus, David will keep you informed with a full year of updates and guidance on MAKO Surgical as news breaks. Click here now to learn more and start reading.